成分檢驗報告
口服低劑量 Minoxidil
英文名稱:Low-Dose Oral Minoxidil (LDOM)
- 共有幾筆評級
- 4 筆
- 資料日期
- 2026-06-09
- 台灣規定
- 台灣有獨立規範
檢驗結果
| 用在哪裡 | 證據等級 | 分數(滿分 100) | 要注意的地方 |
|---|---|---|---|
| 雄性禿 (AGA) | A 中度證據 | 73 |
|
| 女性雄性禿 (FPHL) | B 初步證據 | 69 |
|
| 暫禿症 / 休止期落髮 | C 薄弱證據 | 67 |
|
| 圓禿 / 鬼剃頭 | C 薄弱證據 | 50 |
|
逐筆明細
保健成分 × 適應症
口服低劑量 Minoxidil × 雄性禿 (AGA)
白話說:中度證據,有一定的支持。
發布狀態:可參考,但附帶但書
- 第三方營養資料庫(國際)
展開原文引用
「Low-dose oral minoxidil (LDOM, 0.25-5mg/day) is an off-label repurposing of the antihypertensive drug Loniten for androgenetic alopecia and other hair loss disorders, gaining mainstream dermatology ad」 - 美國 FDA 態度:持保留
展開原文引用
「BOXED WARNING: 'Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent ta…」 - 歐盟 EFSA 態度:持保留
展開原文引用
「Minoxidil and its salts must not be used in cosmetic products because of their antihypertensive activity. Minoxidil absorption after scalp application could lead to systemic effects. [Minoxidil is] a peripheral vasodilatator acting on vascular smooth muscle cells, used as a drug in the management of severe hypertension. [The substance is] cardiotoxic in long term oral studies.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v4。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面
保健成分 × 適應症
口服低劑量 Minoxidil × 女性雄性禿 (FPHL)
白話說:有初步證據,但研究規模還小,別當成定論。
發布狀態:可參考,但附帶但書
- 第三方營養資料庫(國際)
展開原文引用
「Low-dose oral minoxidil (LDOM, 0.25-5mg/day) is an off-label repurposing of the antihypertensive drug Loniten for androgenetic alopecia and other hair loss disorders, gaining mainstream dermatology ad」 - 美國 FDA 態度:持保留
展開原文引用
「BOXED WARNING: 'Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent ta…」 - 歐盟 EFSA 態度:持保留
展開原文引用
「Minoxidil and its salts must not be used in cosmetic products because of their antihypertensive activity. Minoxidil absorption after scalp application could lead to systemic effects. [Minoxidil is] a peripheral vasodilatator acting on vascular smooth muscle cells, used as a drug in the management of severe hypertension. [The substance is] cardiotoxic in long term oral studies.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v4。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面
保健成分 × 適應症
口服低劑量 Minoxidil × 暫禿症 / 休止期落髮
白話說:證據還很薄弱,不足以當成有效的療法。
發布狀態:可參考,但附帶但書
- 第三方營養資料庫(國際)
展開原文引用
「Low-dose oral minoxidil (LDOM, 0.25-5mg/day) is an off-label repurposing of the antihypertensive drug Loniten for androgenetic alopecia and other hair loss disorders, gaining mainstream dermatology ad」 - 美國 FDA 態度:持保留
展開原文引用
「BOXED WARNING: 'Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent ta…」 - 歐盟 EFSA 態度:持保留
展開原文引用
「Minoxidil and its salts must not be used in cosmetic products because of their antihypertensive activity. Minoxidil absorption after scalp application could lead to systemic effects. [Minoxidil is] a peripheral vasodilatator acting on vascular smooth muscle cells, used as a drug in the management of severe hypertension. [The substance is] cardiotoxic in long term oral studies.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v5。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面
保健成分 × 適應症
口服低劑量 Minoxidil × 圓禿 / 鬼剃頭
白話說:證據還很薄弱,不足以當成有效的療法。
發布狀態:可參考,但附帶但書
- 第三方營養資料庫(國際)
展開原文引用
「Low-dose oral minoxidil (LDOM, 0.25-5mg/day) is an off-label repurposing of the antihypertensive drug Loniten for androgenetic alopecia and other hair loss disorders, gaining mainstream dermatology ad」 - 美國 FDA 態度:持保留
展開原文引用
「BOXED WARNING: 'Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent ta…」 - 歐盟 EFSA 態度:持保留
展開原文引用
「Minoxidil and its salts must not be used in cosmetic products because of their antihypertensive activity. Minoxidil absorption after scalp application could lead to systemic effects. [Minoxidil is] a peripheral vasodilatator acting on vascular smooth muscle cells, used as a drug in the management of severe hypertension. [The substance is] cardiotoxic in long term oral studies.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v4。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 證據資料庫原始頁面